Chinese National Accused Of Offering S$100 Bribe To HSA Officer Over Unregistered Medical Devices
A 35-year-old Chinese national has been charged in Singapore after allegedly attempting to bribe a Health Sciences Authority (HSA) officer during an enforcement investigation linked to unregistered medical devices.
According to the Corrupt Practices Investigation Bureau, Wang Siling allegedly offered S$100 to an HSA investigation officer on Apr. 22, 2026. The alleged payment was reportedly intended to persuade the officer not to take enforcement action against her and her husband.
Authorities said the case involved the importation of unregistered medical devices that were meant for exhibition purposes at the Marina Bay Sands Convention Centre in Singapore.
The officer rejected the alleged bribe, and the matter was later referred to the CPIB for further investigation. Wang was formally charged in court on May 14, 2026.
Singapore Maintains Strict Anti-Corruption Enforcement
Under Singapore law, corruption offences are treated seriously regardless of the amount involved. Wang faces one charge under Section 6(b) of the Prevention of Corruption Act.
If convicted, she could face a fine of up to S$100,000, a jail sentence of up to five years, or both.
The CPIB reiterated Singapore’s firm stance against corruption, stating that the country adopts a “strict zero-tolerance approach” towards such offences. Singapore is widely recognised globally for its strong anti-corruption framework, strict financial compliance measures, and transparent business regulations, which are often cited as key factors supporting the nation’s banking, insurance, and corporate investment sectors.
Cases involving unregistered medical products and healthcare devices have also drawn increasing scrutiny in recent years, especially as Singapore strengthens oversight in areas involving medical technology, healthcare compliance, and cross-border imports.
Medical Device Regulations In Singapore Remain Tight
The HSA regulates the import, supply, and distribution of medical devices in Singapore to ensure consumer safety and compliance with healthcare standards. Businesses bringing medical devices into the country for exhibitions, retail, or commercial use are typically required to meet registration and approval requirements before the products can be displayed or distributed.
Industry observers note that Singapore’s healthcare and pharmaceutical sectors continue to attract major international investments due to the country’s reputation for regulatory reliability and strong governance.
The case involving Wang Siling remains before the courts, with further proceedings expected in the coming months.